Today during trading, shares of Antibe Therapeutics Inc opened at $0.26 and closed at $0.29. prices ranged from a low of $0.26 to a high of $0.35.

Share prices advanced 13.46% from the previous day's close of $0.26.

Today across North America, the TSX Composite closed 0.05% at 21885.38, the S&P 500 closed 0.02% at 5071.63, the Dow Jones Industrial Average closed -0.11% at 38460.92 and the Nasdaq Composite closed 0.10% at 15712.75.

Antibe Therapeutics Inc traded under ATE on the Toronto Stock Exchange (TSX).

A total of 167,044 shares was traded during the last trading day, with total trades of 93, with an average volume of 331,146 over 5 days.

The TSX overall saw 1,786 price advancers against 3,411 declines and 112 unchanged.

During the prior 52 weeks, ATE.TO has traded as high as $1.23 (November 09,2023) and low as $0.15 (April 01,2024). Moreover, in the last 52 weeks, Antibe Therapeutics Inc's shares have shrunken -47.32 percent, while in 2024, they have shrunken -68.28%.

Following today's trading, Antibe Therapeutics Inc has a market capitalization of $15.64 million on a float of 53,009 shares outstanding. Its annual EPS is $-0.35.

Antibe Therapeutics Inc is a None company headquartered in Toronto, CAN.

Currently, Antibe Therapeutics Inc's consensus rating is "Moderate Sell" based on 2 analysts according to Zacks. From those 2 analysts, 1 have sell ratings and 1 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..